NCT01688960 2015-03-17Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid MalignanciesRegeneron PharmaceuticalsPhase 1 Completed48 enrolled
NCT00622414 2014-02-24Aflibercept in Treating Young Patients With Relapsed or Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed27 enrolled